MoC E (35) included BMI screening, waist–hip ratio, ultrasound to assess for non-alcoholic fatty liver disease, and screening for metabolic syndrome, including a 2-hour oral glucose tolerance test, insulin, and lipid profile. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.